Quadrivalent HPV vaccination reactions: More hype than harm

Australian Family Physician

Volumn 38, Issue 3, 2009, Pages 139-142

  Douglas, Robert J ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; AUSTRALIA; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG TOXICITY; FEMALE; HUMAN; SUBCUTANEOUS EMPHYSEMA; VIRUS INFECTION;

ADULT; AUSTRALIA; DRUG TOXICITY; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SUBCUTANEOUS EMPHYSEMA; TUMOR VIRUS INFECTIONS;

EID: 67649227242     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Penalba Citores A, Adrian Gutierrez J, Hernandez-Sampelayo MT, et al. Subcutaneous emphysema after the administration of hepatitis B vaccine. Acta Pediatr Esp 2006;64:458-9.
2. Rossiter JL, Hendrix RA. Iatrogenic subcutaneous cervicofacial and mediastinal emphysema. J Otolaryngol 1991;20:315-9.
3. Shackleford D, Casani JA. Diffuse subcutaneous emphysema, pneumomediastinum, and pneumothorax after dental extraction. Ann Emerg Med 1993;22;248-50.
4. Bard PA, Chen L. Subcutaneous emphysema associated with laparoscopy. Anesth Analg 1990;71;101-2.
5. Prober A, Tverskoy M. A rare cause of subcutaneous emphysema. Rontgenblatter 1986;39:360-1.
6. Miller NB. Clinical review of Biologics License Application for Human papillomavirus 6,11,16,18 L1 virus-like particle vaccine (S. cerevisae) (STN 125126 GARDASIL), manufactured by Merck, Inc. Available at www.fda.gov/cber/review/hpvmer060806r.pdf [Accessed 31 July 2008].
7. Australian Immunisation Handbook, 9th edn. 2008 (NHMRC). Available at www.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook-home[Accessed 1 August 2008].
8. Vaccine Information SA. Available at www.visainfo.org.au.
9. National Vaccine Information Centre. Available at www.nvic.org.
10. The Age, Melbourne. 22 May 2007, p.7.
11. The Australian, Adelaide. 23 May 2007, p.3.
12. Clements CJ. Gardasil and mass psychogenic illness. Aust N Z J Public Health 2007;31:387.
13. Clements CJ. Mass psychogenic illness after vaccination. Drug Saf 2003;26:599-604.
14. Kharabsheh S, Al-Otoum H, Clements J, et al. Mass psychogenic illness following tetanus-diphtheria toxoid vaccination in Jordan. Bull World Health Organ 2001;79:764-70.
15. Khiem HB, Huan Ie D, Phuong NT, et al. Mass psychogenic illness following oral cholera immunisation in Ca Mau City, Vietnam. Vaccine 2003;21:4527-31.
16. Centers for Disease Control and Prevention (CDC). Syncope after vaccination - United States, January 2005-July 2007. MMWR Morb Mortal Wkly Rep 2008;57:457-60.
17. Reeve C, De La Rue S, Pashen D, et al. School-based vaccinations delivered by general practice in rural north Queensland: an evaluation of a new human papilloma virus vaccination program. Commun Dis Intell 2008;32:94-8.
18. Brabin L, Roberts SA, Stretch R, et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 2008;336:1056-8.
19. Therapeutic Goods Administration, Australian Government Department of Health and Ageing. Human papillomavirus vaccine (GARDASIL). Available at www.tga.gov.au/alerts/medicines/gardasil.htm [Accessed 1 August 2008].
20. Brotherton JML, Gold MS, Kemp AS, et al. Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ 2008;179:525-33.
21. Ruggeberg JU, Gold MS, Bayas JM, et al. The Brighton Collaboration Anaphylaxis Working Group. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2007;25:5675-84.
22. Bohlke K, Davis RL, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003;112:815-20.
23. Centers for Disease Control and Prevention. Vaccine safety - Vaccine Adverse Event Reporting System (VAERS) - Gardasil reports. Available at www.cdc.gov/vaccinesafety/vaers/gardasil.htm [Accessed 1 August 2008].